Caxton »

Alx Oncology Hldgs shares owned by Caxton

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by Caxton from 13F filings

Historical chart of Caxton investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by Caxton consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by Caxton

Quarter filed Position value Share count Share price at filing
2026-03-31 $42k 21k 2.01

More positions owned by Caxton

Spdr Gold Tr Gold Shs (GLD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Kyverna Therapeutics (KYTX)
Lexeo Therapeutics (LXEO)
X4 Pharmaceuticals Com New (XFOR)
Inhibikase Therapeutics Com New (IKT)
Alx Oncology Hldgs (ALXO)

View all positions for Caxton

Top funds holding Alx Oncology Hldgs

RA Capital Management
TCG Crossover Management
venBio Partners
Redmile Group
Blackstone Group
Vanguard Capital Management
Vivo Capital
Almitas Capital
5AM Venture Management
OrbiMed Advisors
Millennium Management
Vanguard Group
Two Sigma Investments
Squadron Capital Management
Driehaus Capital Management

View all funds holding Alx Oncology Hldgs